IMX-110 Surpasses Standard of Care in Mice Cancer Study

IMX-110 Surpasses Standard of Care in Mice Cancer Study

Immix Biopharma, Inc. (NASDAQ:IMMX)

Format

PNG

Source

Immix Biopharma, Inc.

Téléchargements